Postgraduate Institute of Medical Education and Research, Chandigarh
स्नातकोत्तर चिकित्सा शिक्षा एवं अनुसंधान संस्थान, चंडीगढ़
Administration Login
HealthEcon Publication Banner
Showing 61 to 70 of 292 entries

Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India.

IJMR Indian Journal of Medical Research

Singh M, Sharma A, Bahuguna P, Jyani G, Prinja S.

2022 Open Access

Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study.

GCU Glasgow Caledonian University

Chugh Y, Jyani G, Trivedi M, Albert S, Kar SS, Patro B, Raman S, Rajsekar K, Baker RM, Donaldson C, Prinja S.

2022 Open Access

Cost of delivering Primary Health Care through Public Sector in India.

Europe PMC

Chauhan AS, Prinja S, Spuelvaraj S, Gupta A, Muraleedharan VR, Sundararaman T.

2022 Open Access

Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India. Appl Health Econ Health Policy.

Springer Link

Chugh Y, Bahuguna P, Sohail A, Rajsekar K, Muraleedharan VR, Prinja S

2022 Open Access

Health-related quality of life among breast cancer patients in India.

Support Care Cancer

Gupta N, Pandey AK, Dimri K, Jyani G, Goyal A, Prinja S.

2022 Open Access

The Dynamics of Health, Productivity, and Development: A Policy Prescription.

ProQuest

Purohit N, Prinja S

2022 Open Access

Cost-effectiveness of Post-Mastectomy Radiotherapy (PMRT) for breast cancer in India: An economic modelling study.

The LANCET Regional Health Southeast Asia

Gupta N, Chugh Y, Chauhan AS, Pramesh CS, Prinja S

2022 Open Access

Costing of services under National Tuberculosis Elimination Program at public health facilities of northern India. 2022. Forthcoming

ScienceDirect

Kumar D, Prinja S.

2022 Open Access

Financing Comprehensive Immunization Services in Lao PDR: A fiscal space analysis from a public policy perspective.

NIH - National Library of Medical - Appl Health Econ Health Policy

Bahuguna P, Masaki E, Jeet G, Prinja S.

2022 Open Access

Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone ReceptorPositive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.

Europe PMC - Health Economics and Health Policy.

Gupta N, Gupta D, Dixit J, Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS.

2022 Open Access